Detailed price information for Assembly Biosciences (ASMB-Q) from The Globe and Mail including charting and trades.
We’re back with our roundup of the most insightful studies of the year, from the power of brain breaks to groundbreaking ...
The best PFS results we’ve ever seen in relapsed, refractory myeloma.”The combination of teclistamab (Tecvayli, Janssen) plus ...
The agency’s proposed European Resilience from Space (ERS) project secured almost all the funding it had sought. It aims to create a military-grade “system of systems” pooling national space assets to ...
The Pensacola News Journal is working with high schools in Escambia and Santa Rosa County to put their top students in the ...
Long the titan of prep schools in Los Angeles, with a reputation as an Ivy League feeder, Harvard-Westlake has seen the ...
Get timely market insights with weekly economic indicators. Click for trends in mortgage apps, labor market signals, and what ...
Explore the economic indicators, yield curve insights, and consumer spending trends to inform your investment strategy. Click ...
At the 13-week primary endpoint, ASC30 once-daily tablets showed dose-dependent placebo-adjusted mean body weight reductions of 5.4%, 7.0% and 7.7% for 20 mg, 40 mg and 60 mg, respectively. No plateau ...
MedPage Today on MSN
Bispecific Trial in Myeloma Sparks Talks of 'Functional Cure'
The complete response or better rate was 81.1% with the combination versus 31.1% in the control arm, while patients treated ...
Treatment with rituximab plus epcoritamab has achieved rapid and deep responses in follicular lymphoma patients with a high tumor burden.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results